Target intelligence / Profile preview

Crystallin gamma F, pseudogene (CRYGFP)

Target
CRYGFP
Molecular classification
Other (pseudogene, gamma-crystallin gene family)
01

Overview

Crystallin gamma F, pseudogene (CRYGFP) is part of the human gamma-crystallin gene cluster located on chromosome 2q34[2]. While in some mammals it encodes a structural lens protein, in humans it is designated a pseudogene: the gene sequence remains largely intact but there is no evidence of functional expression—neither mRNA nor protein has been detected[2]. Pseudogenes like CRYGFP may have potential, though rare, roles in gene conversion events but are not expressed under normal physiological conditions. The gamma-crystallin family forms highly stable lens proteins important for transparency and refractive index, but CRYGFP itself does not contribute to these functions in humans[1][2]. It is not implicated in disease, not known to interact with drugs, and is not used as a biomarker. It does not belong to molecular classes typically considered druggable targets (e.g., receptor, enzyme, transporter)[2].\n\nThe designation as a pseudogene means it is a relic of gene duplication and evolutionary processes. Species like mice have a functional gamma-crystallin F; in humans, loss of function is typical for this locus[2]. Only CRYGC and CRYGD within this gene cluster are major contributors to lens structure and some forms of hereditary cataract, but CRYGFP has no such role[2]. \n\nIf you are seeking a therapeutic target or protein relevant to disease, CRYGFP does not meet those criteria. The information provided above follows conventions to clarify its status and classification.

Other names
CRYGFPgamma-crystallin F pseudogenep1

Beyond the preview

Go deeper on Crystallin gamma F, pseudogene (CRYGFP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crystallin gamma F, pseudogene (CRYGFP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call